EA

Eagle Veterinary Technology Co.,Ltd

Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.

044960 | KO

Overview

Corporate Details

ISIN(s):
KR7044960003
LEI:
Country:
South Korea
Address:
충청남도 예산군 신암면 추사로 235-34, 예산군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1970, Eagle Veterinary Technology Co., Ltd. is a specialized company in animal health, manufacturing and distributing veterinary pharmaceuticals and premium pet food. Its pharmaceutical division serves the livestock (cattle, swine, poultry) and aquaculture industries, offering a range of products including antibiotics, anthelmintics, and innovative bio-feeds developed through partnerships with global firms. The companion animal division, Haruwell, focuses on the premium market by distributing international brands like Now Fresh, Go! Solutions, and CARU, while also developing its own functional product lines such as the 'Probiomil' probiotic feed and 'SUMMIT' tailored nutrition diets. The company is committed to research and development to improve animal well-being and actively engages with its markets through industry seminars, consumer expos, and corporate social responsibility initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-19 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2025-03-11 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 652.9 KB
2025-02-21 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 178.9 KB
2025-02-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.0 KB
2025-02-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.7 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 870.7 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 864.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 873.5 KB
2024-03-29 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.0 KB
2024-03-21 00:00
Audit Report / Information
사업보고서 (2023.12)
Korean 548.1 KB
2024-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2024-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 166.2 KB

Automate Your Workflow. Get a real-time feed of all Eagle Veterinary Technology Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eagle Veterinary Technology Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eagle Veterinary Technology Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Onesano S.A. Logo
Develops patented nutritional products for humans, animals, and agriculture.
Poland
SKT
OnKure Therapeutics, Inc. Logo
Developing less toxic, tumor-agnostic kinase inhibitors for precision cancer therapy.
United States of America
OKUR
ONO PHARMACEUTICAL CO., LTD. Logo
Develops innovative medicines for high unmet needs in oncology, immunology, and neurology.
Japan
4528
OPKO Health Inc. Logo
Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.
Israel
OPK
OPKO HEALTH, INC. Logo
A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.
United States of America
OPK
Opthea Ltd Logo
Biopharma that discontinued its wet AMD therapy after its lead drug failed Phase 3 trials.
United States of America
OPT
OPTUS Pharmaceutical Co., Ltd. Logo
Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.
South Korea
131030
Opus Genetics, Inc. Logo
Developing gene therapies for inherited retinal diseases and other blinding conditions.
United States of America
IRD
ORAGENICS INC Logo
Biotech developing intranasal drugs for concussion and other brain disorders.
United States of America
OGEN
Oramed Pharmaceuticals Inc. Logo
Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.
Israel
ORMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.